BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 2802800)

  • 1. Anticentromere antibody in patients without CREST and scleroderma: association with active digital vasculitis, rheumatic and connective tissue disease.
    Goldman JA
    Ann Rheum Dis; 1989 Sep; 48(9):771-5. PubMed ID: 2802800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anticentromere antibodies. Diagnostic and prognostic value].
    Meyer O; Haïm T
    Nouv Presse Med; 1982 Oct; 11(39):2891-4. PubMed ID: 6755388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of anticentromere antibody in idiopathic Raynaud's syndrome.
    Sarkozi J; Bookman AA; Lee P; Keystone EC; Fritzler MJ
    Am J Med; 1987 Nov; 83(5):893-8. PubMed ID: 3314499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The clinical significance of anti-ENA antibodies and anticentromere antibody (ACA) in patients with sclerodermatous skin changes and Raynaud's phenomenon].
    Uchida K; Kondo H; Kashiwazaki S
    Ryumachi; 1984 Aug; 24(4):241-9. PubMed ID: 6334895
    [No Abstract]   [Full Text] [Related]  

  • 5. The CREST syndrome: a distinct serologic entity with anticentromere antibodies.
    Fritzler MJ; Kinsella TD
    Am J Med; 1980 Oct; 69(4):520-6. PubMed ID: 6968511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticentromere antibody and immunoglobulin allotypes in scleroderma.
    Chen ZY; Fedrick JA; Pandey JP; Silver R; Maricq HR; Fudenberg HH; Dobson RL; Ainsworth SK
    Arch Dermatol; 1985 Mar; 121(3):339-44. PubMed ID: 3883903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A long-term longitudinal study of anticentromere antibodies.
    Tramposch HD; Smith CD; Senecal JL; Rothfield N
    Arthritis Rheum; 1984 Feb; 27(2):121-4. PubMed ID: 6607733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodies.
    Kallenberg CG; Pastoor GW; Wouda AA; The TH
    Ann Rheum Dis; 1982 Aug; 41(4):382-7. PubMed ID: 7051989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of primary Raynaud's phenomenon (Raynaud's disease) to connective tissue disease.
    Gerbracht DD; Steen VD; Ziegler GL; Medsger TA; Rodnan GP
    Arthritis Rheum; 1985 Jan; 28(1):87-92. PubMed ID: 3871330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticentromere antibody and primary pulmonary hypertension.
    Seibold JR; Trontell MC
    J Rheumatol; 1982; 9(4):607-9. PubMed ID: 6752406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticentromere antibody: an immunological marker of a subset of systemic sclerosis.
    Chorzelski TP; Jablonska S; Beutner EH; Blaszczyk M; Jarzabek-Chorzelska M; Kencka D; Krasny S; Kumar V; Tchórzewska A
    Br J Dermatol; 1985 Oct; 113(4):381-9. PubMed ID: 3877519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticentromere antibody--clinical associations. A study of 44 patients.
    Caramaschi P; Biasi D; Manzo T; Carletto A; Poli F; Bambara LM
    Rheumatol Int; 1995; 14(6):253-5. PubMed ID: 7597381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Significance of anti-centromere antibodies. Clinical value].
    Meyer O; Haim T; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):261-6. PubMed ID: 6348931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal study of patients with anticentromere antibody.
    Takehara K; Soma Y; Igarashi A; Kikuchi K; Tamaki T; Ishibashi Y
    Dermatologica; 1990; 181(3):202-6. PubMed ID: 2135387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The clinical spectrum of patients with anticentromere antibodies].
    Insua Vilariño S; de la Hera Martínez M; Rodríguez-Valverde V; Merino Pérez J; Alonso Valdivieso JL; Ruiz T
    Rev Clin Esp; 1993 Apr; 192(6):260-4. PubMed ID: 8497719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-centromere antibody, biological marker of the CREST syndrome as distinct from scleroderma].
    Rouquette-Gally AM; Stern MH; Prost AC; Abuaf N; Homberg JC; Combrisson A
    Presse Med; 1985 Jul 13-20; 14(28):1497-500. PubMed ID: 2931679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Raynaud's phenomenon and anticentromere antibodies].
    Marquet Palomer R; Vilardell Tarrés M; Ordi Ros J
    Med Clin (Barc); 1987 Nov; 89(17):721-4. PubMed ID: 3501051
    [No Abstract]   [Full Text] [Related]  

  • 18. Anticentromere antibody positive CREST syndrome associated with polyarthritis, renal impairment and mixed cryoglobulinaemia.
    Shetty HG; O'Sullivan MM; Amos N; Williams BD
    Clin Rheumatol; 1989 Sep; 8(3):381-5. PubMed ID: 2805613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticentromere and anticentriole antibodies in the scleroderma spectrum.
    Tuffanelli DL; McKeon F; Kleinsmith DM; Burnham TK; Kirschner M
    Arch Dermatol; 1983 Jul; 119(7):560-6. PubMed ID: 6859899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteins responsible for anticentromere activity found in the sera of patients with CREST-associated Raynaud's phenomenon.
    Kremer L; Alvaro-Gracia JM; Ossorio C; Avila J
    Clin Exp Immunol; 1988 Jun; 72(3):465-9. PubMed ID: 3048807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.